{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:27:05Z","timestamp":1785882425440,"version":"3.56.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceutica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","ajconline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.amjcard.2024.08.027","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:05:10Z","timestamp":1725321910000},"page":"28-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Improved Risk Prediction Using a Refined European Guidelines Instrument in Pulmonary Arterial Hypertension Related to Congenital Heart Disease"],"prefix":"10.1016","volume":"233","author":[{"given":"Alexandra C.","family":"van Dissel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"D'Alto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Farro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold","family":"Mathijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco C.","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier P.","family":"Bassareo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie P.J.","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J.M.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1433-9692","authenticated-orcid":false,"given":"Berto J.","family":"Bouma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2024.08.027_bib0001","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jacc.2011.03.033","article-title":"Diagnosis of pulmonary hypertension in the congenital heart disease adult population impact on outcomes","volume":"58","author":"Lowe","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0002","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0003","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0004","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00740-2017","article-title":"Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model","volume":"50","author":"Hoeper","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0005","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1093\/eurheartj\/ehx257","article-title":"A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension","volume":"39","author":"Kylhammar","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0006","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00889-2017","article-title":"Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension","volume":"50","author":"Boucly","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0007","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijcard.2018.08.084","article-title":"Risk stratification strategy and assessment of disease progression in patients with pulmonary arterial hypertension: updated Recommendations from the Cologne Consensus Conference 2018","volume":"272S","author":"Leuchte","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0008","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/eurheartj\/eht072","article-title":"Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups","volume":"35","author":"Manes","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0009","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.09-1140","article-title":"Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry","volume":"137","author":"Badesch","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0010","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.amjcard.2013.09.032","article-title":"Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry)","volume":"113","author":"Barst","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0011","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.amjcard.2011.12.003","article-title":"Right ventricular function in patients with Eisenmenger syndrome","volume":"109","author":"Van De Bruaene","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0012","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1161\/CIRCULATIONAHA.112.091421","article-title":"Echocardiographic predictors of outcome in Eisenmenger syndrome","volume":"126","author":"Moceri","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0013","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00248-2018","article-title":"Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients","volume":"52","author":"Delcroix","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0014","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.chest.2019.02.004","article-title":"Predicting survival in patients with pulmonary arterial hypertension: the REVEAL risk score Calculator 2.0 and comparison with ESC\/ERS-based risk assessment strategies","volume":"156","author":"Benza","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0015","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijcard.2014.11.222","article-title":"New predictors of mortality in adults with congenital heart disease and pulmonary hypertension: midterm outcome of a prospective study","volume":"181","author":"Schuuring","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0016","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/ehjci\/jew068","article-title":"Tricuspid annular plane systolic excursion is preserved in young patients with pulmonary hypertension except when associated with repaired congenital heart disease","volume":"18","author":"Hauck","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0017","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/eurheartj\/ehr461","article-title":"Reference values for exercise limitations among adults with congenital heart disease. Relation to activities of daily life\u2013single centre experience and review of published data","volume":"33","author":"Kempny","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0018","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijcard.2015.10.074","article-title":"Diagnostic value of the six-minute walk test (6MWT) in grown-up congenital heart disease (GUCH): comparison with clinical status and functional exercise capacity","volume":"203","author":"Kehmeier","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0019","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.106.630715","article-title":"Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study","volume":"114","author":"Gali\u00e8","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0020","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/eurheartj\/ehv743","article-title":"German Competence Network for Congenital Heart Defects Investigators. Current therapy and outcome of Eisenmenger syndrome: data of the German National Register for congenital heart defects","volume":"37","author":"Diller","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0021","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.amjcard.2010.12.051","article-title":"Ambrisentan for pulmonary arterial hypertension due to congenital heart disease","volume":"107","author":"Zuckerman","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0022","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCULATIONAHA.109.883876","article-title":"Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension","volume":"121","author":"Dimopoulos","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0023","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijcard.2010.10.051","article-title":"Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology","volume":"155","author":"D'Alto","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0024","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01401-2019","article-title":"The effects of parenteral prostacyclin therapy as add-on treatment to oral compounds in Eisenmenger syndrome","volume":"54","author":"D'Alto","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0025","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","article-title":"Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension","volume":"373","author":"Gali\u00e8","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0026","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1183\/13993003.02043-2015","article-title":"Initial dual oral combination therapy in pulmonary arterial hypertension","volume":"47","author":"Sitbon","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0027","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.chest.2019.09.009","article-title":"Risk reduction and right heart reverse remodeling by upfront triple combination therapy in pulmonary arterial hypertension","volume":"157","author":"D'Alto","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0028","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1093\/eurheartj\/ehx201","article-title":"Past and current cause-specific mortality in Eisenmenger syndrome","volume":"38","author":"Hjortsh\u00f8j","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2024.08.027_bib0029","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1183\/09031936.00092311","article-title":"The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension","volume":"39","author":"Nickel","year":"2012","journal-title":"Eur Respir J"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914924006271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914924006271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T16:48:15Z","timestamp":1732294095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914924006271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":29,"alternative-id":["S0002914924006271"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2024.08.027","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved Risk Prediction Using a Refined European Guidelines Instrument in Pulmonary Arterial Hypertension Related to Congenital Heart Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2024.08.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}